Cargando…

Contemporary incidence and risk factors of post transplant Erythrocytosis in deceased donor kidney transplantation

BACKGROUND: Post-Transplant erythrocytosis (PTE) has not been studied in large recent cohorts. In this study, we evaluated the incidence, risk factors, and outcome of PTE with current transplant practices using the present World Health Organization criteria to define erythrocytosis. We also tested t...

Descripción completa

Detalles Bibliográficos
Autores principales: Alasfar, Sami, Hall, Isaac E., Mansour, Sherry G., Jia, Yaqi, Thiessen-Philbrook, Heather R., Weng, Francis L., Singh, Pooja, Schröppel, Bernd, Muthukumar, Thangamani, Mohan, Sumit, Malik, Rubab F., Harhay, Meera N., Doshi, Mona D., Akalin, Enver, Bromberg, Jonathan S., Brennan, Daniel C., Reese, Peter P., Parikh, Chirag R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802150/
https://www.ncbi.nlm.nih.gov/pubmed/33435916
http://dx.doi.org/10.1186/s12882-021-02231-2
_version_ 1783635712852099072
author Alasfar, Sami
Hall, Isaac E.
Mansour, Sherry G.
Jia, Yaqi
Thiessen-Philbrook, Heather R.
Weng, Francis L.
Singh, Pooja
Schröppel, Bernd
Muthukumar, Thangamani
Mohan, Sumit
Malik, Rubab F.
Harhay, Meera N.
Doshi, Mona D.
Akalin, Enver
Bromberg, Jonathan S.
Brennan, Daniel C.
Reese, Peter P.
Parikh, Chirag R.
author_facet Alasfar, Sami
Hall, Isaac E.
Mansour, Sherry G.
Jia, Yaqi
Thiessen-Philbrook, Heather R.
Weng, Francis L.
Singh, Pooja
Schröppel, Bernd
Muthukumar, Thangamani
Mohan, Sumit
Malik, Rubab F.
Harhay, Meera N.
Doshi, Mona D.
Akalin, Enver
Bromberg, Jonathan S.
Brennan, Daniel C.
Reese, Peter P.
Parikh, Chirag R.
author_sort Alasfar, Sami
collection PubMed
description BACKGROUND: Post-Transplant erythrocytosis (PTE) has not been studied in large recent cohorts. In this study, we evaluated the incidence, risk factors, and outcome of PTE with current transplant practices using the present World Health Organization criteria to define erythrocytosis. We also tested the hypothesis that the risk of PTE is greater with higher-quality kidneys. METHODS: We utilized the Deceased Donor Study which is an ongoing, multicenter, observational study of deceased donors and their kidney recipients that were transplanted between 2010 and 2013 across 13 centers. Eryrthocytosis is defined by hemoglobin> 16.5 g/dL in men and> 16 g/dL in women. Kidney quality is measured by Kidney Donor Profile Index (KDPI). RESULTS: Of the 1123 recipients qualified to be in this study, PTE was observed at a median of 18 months in 75 (6.6%) recipients. Compared to recipients without PTE, those with PTE were younger [mean 48±11 vs 54±13 years, p < 0.001], more likely to have polycystic kidney disease [17% vs 6%, p < 0.001], have received kidneys from younger donors [36 ±13 vs 41±15 years], and be on RAAS inhibitors [35% vs 22%, p < 0.001]. Recipients with PTE were less likely to have received kidneys from donors with hypertension [16% vs 32%, p = 0.004], diabetes [1% vs 11%, p = 0.008], and cerebrovascular event (24% vs 36%, p = 0.036). Higher KDPI was associated with decreased PTE risk [HR 0.98 (95% CI: 0.97–0.99)]. Over 60 months of follow-up, only 17 (36%) recipients had sustained PTE. There was no association between PTE and graft failure or mortality, CONCLUSIONS: The incidence of PTE was low in our study and PTE resolved in majority of patients. Lower KDPI increases risk of PTE. The underutilization of RAAS inhibitors in PTE patients raises the possibility of under-recognition of this phenomenon and should be explored in future studies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-021-02231-2.
format Online
Article
Text
id pubmed-7802150
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78021502021-01-12 Contemporary incidence and risk factors of post transplant Erythrocytosis in deceased donor kidney transplantation Alasfar, Sami Hall, Isaac E. Mansour, Sherry G. Jia, Yaqi Thiessen-Philbrook, Heather R. Weng, Francis L. Singh, Pooja Schröppel, Bernd Muthukumar, Thangamani Mohan, Sumit Malik, Rubab F. Harhay, Meera N. Doshi, Mona D. Akalin, Enver Bromberg, Jonathan S. Brennan, Daniel C. Reese, Peter P. Parikh, Chirag R. BMC Nephrol Research Article BACKGROUND: Post-Transplant erythrocytosis (PTE) has not been studied in large recent cohorts. In this study, we evaluated the incidence, risk factors, and outcome of PTE with current transplant practices using the present World Health Organization criteria to define erythrocytosis. We also tested the hypothesis that the risk of PTE is greater with higher-quality kidneys. METHODS: We utilized the Deceased Donor Study which is an ongoing, multicenter, observational study of deceased donors and their kidney recipients that were transplanted between 2010 and 2013 across 13 centers. Eryrthocytosis is defined by hemoglobin> 16.5 g/dL in men and> 16 g/dL in women. Kidney quality is measured by Kidney Donor Profile Index (KDPI). RESULTS: Of the 1123 recipients qualified to be in this study, PTE was observed at a median of 18 months in 75 (6.6%) recipients. Compared to recipients without PTE, those with PTE were younger [mean 48±11 vs 54±13 years, p < 0.001], more likely to have polycystic kidney disease [17% vs 6%, p < 0.001], have received kidneys from younger donors [36 ±13 vs 41±15 years], and be on RAAS inhibitors [35% vs 22%, p < 0.001]. Recipients with PTE were less likely to have received kidneys from donors with hypertension [16% vs 32%, p = 0.004], diabetes [1% vs 11%, p = 0.008], and cerebrovascular event (24% vs 36%, p = 0.036). Higher KDPI was associated with decreased PTE risk [HR 0.98 (95% CI: 0.97–0.99)]. Over 60 months of follow-up, only 17 (36%) recipients had sustained PTE. There was no association between PTE and graft failure or mortality, CONCLUSIONS: The incidence of PTE was low in our study and PTE resolved in majority of patients. Lower KDPI increases risk of PTE. The underutilization of RAAS inhibitors in PTE patients raises the possibility of under-recognition of this phenomenon and should be explored in future studies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-021-02231-2. BioMed Central 2021-01-12 /pmc/articles/PMC7802150/ /pubmed/33435916 http://dx.doi.org/10.1186/s12882-021-02231-2 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Alasfar, Sami
Hall, Isaac E.
Mansour, Sherry G.
Jia, Yaqi
Thiessen-Philbrook, Heather R.
Weng, Francis L.
Singh, Pooja
Schröppel, Bernd
Muthukumar, Thangamani
Mohan, Sumit
Malik, Rubab F.
Harhay, Meera N.
Doshi, Mona D.
Akalin, Enver
Bromberg, Jonathan S.
Brennan, Daniel C.
Reese, Peter P.
Parikh, Chirag R.
Contemporary incidence and risk factors of post transplant Erythrocytosis in deceased donor kidney transplantation
title Contemporary incidence and risk factors of post transplant Erythrocytosis in deceased donor kidney transplantation
title_full Contemporary incidence and risk factors of post transplant Erythrocytosis in deceased donor kidney transplantation
title_fullStr Contemporary incidence and risk factors of post transplant Erythrocytosis in deceased donor kidney transplantation
title_full_unstemmed Contemporary incidence and risk factors of post transplant Erythrocytosis in deceased donor kidney transplantation
title_short Contemporary incidence and risk factors of post transplant Erythrocytosis in deceased donor kidney transplantation
title_sort contemporary incidence and risk factors of post transplant erythrocytosis in deceased donor kidney transplantation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802150/
https://www.ncbi.nlm.nih.gov/pubmed/33435916
http://dx.doi.org/10.1186/s12882-021-02231-2
work_keys_str_mv AT alasfarsami contemporaryincidenceandriskfactorsofposttransplanterythrocytosisindeceaseddonorkidneytransplantation
AT hallisaace contemporaryincidenceandriskfactorsofposttransplanterythrocytosisindeceaseddonorkidneytransplantation
AT mansoursherryg contemporaryincidenceandriskfactorsofposttransplanterythrocytosisindeceaseddonorkidneytransplantation
AT jiayaqi contemporaryincidenceandriskfactorsofposttransplanterythrocytosisindeceaseddonorkidneytransplantation
AT thiessenphilbrookheatherr contemporaryincidenceandriskfactorsofposttransplanterythrocytosisindeceaseddonorkidneytransplantation
AT wengfrancisl contemporaryincidenceandriskfactorsofposttransplanterythrocytosisindeceaseddonorkidneytransplantation
AT singhpooja contemporaryincidenceandriskfactorsofposttransplanterythrocytosisindeceaseddonorkidneytransplantation
AT schroppelbernd contemporaryincidenceandriskfactorsofposttransplanterythrocytosisindeceaseddonorkidneytransplantation
AT muthukumarthangamani contemporaryincidenceandriskfactorsofposttransplanterythrocytosisindeceaseddonorkidneytransplantation
AT mohansumit contemporaryincidenceandriskfactorsofposttransplanterythrocytosisindeceaseddonorkidneytransplantation
AT malikrubabf contemporaryincidenceandriskfactorsofposttransplanterythrocytosisindeceaseddonorkidneytransplantation
AT harhaymeeran contemporaryincidenceandriskfactorsofposttransplanterythrocytosisindeceaseddonorkidneytransplantation
AT doshimonad contemporaryincidenceandriskfactorsofposttransplanterythrocytosisindeceaseddonorkidneytransplantation
AT akalinenver contemporaryincidenceandriskfactorsofposttransplanterythrocytosisindeceaseddonorkidneytransplantation
AT brombergjonathans contemporaryincidenceandriskfactorsofposttransplanterythrocytosisindeceaseddonorkidneytransplantation
AT brennandanielc contemporaryincidenceandriskfactorsofposttransplanterythrocytosisindeceaseddonorkidneytransplantation
AT reesepeterp contemporaryincidenceandriskfactorsofposttransplanterythrocytosisindeceaseddonorkidneytransplantation
AT parikhchiragr contemporaryincidenceandriskfactorsofposttransplanterythrocytosisindeceaseddonorkidneytransplantation